Trials / Conditions / Myeloid Leukemia, Chronic

Myeloid Leukemia, Chronic

12 registered clinical trials studyying Myeloid Leukemia, Chronic.

Status	Trial	Sponsor	Phase
Completed	A Study of Real-world Treatment and Burden of Chronic Myeloid Leukemia Patients in Japan NCT07150793	Novartis Pharmaceuticals	—
Completed	Dasatinib Holiday for Improved Tolerability NCT02890784	University of Jena	Phase 3
Terminated	DC Vaccination in CML NCT02543749	Charite University, Berlin, Germany	Phase 1 / Phase 2
Terminated	Efficacy and Safety Assessment of NIlotinib in CML Patients With Suboptimal Response on Imatinib Therapy NCT02086487	King Abdullah International Medical Research Center	Phase 4
Completed	Phase 1-2 MAHCT w/ TCell Depleted Graft w/ Simultaneous Infusion Conventional and Regulatory T Cell NCT01660607	Stanford University	Phase 1 / Phase 2
Completed	Effect of 2nd Gen TKI in CML NCT02222272	European Society for Blood and Marrow Transplantation	—
Completed	A Phase III Study of Dasatinib vs Imatinib in Patients With Newly Diagnosed Chronic Phase Chronic Myeloid Leuk NCT00481247	Bristol-Myers Squibb	Phase 3
Completed	Evaluation of the Persistence of the Complete Molecular Remission After Stopping Imatinib Chronic Myeloid Leuk NCT00478985	University Hospital, Bordeaux	N/A
Completed	A Study of Dasatinib in Chronic Phase Philadelphia Chromosome Positive Chronic Myeloid Leukemia NCT00482703	Bristol-Myers Squibb	Phase 1 / Phase 2
Unknown	Registration of Children With CML and Treatment With Imatinib NCT00445822	Technische Universität Dresden	—
Terminated	Imatinib Mesylate and Zoledronic Acid in Patients With Chronic Myeloid Leukaemia in Cytogenetic Response Witho NCT00210119	Institut Bergonié	Phase 2
Terminated	Homoharringtonine With Oral Gleevec in Chronic, Accelerated and Blast Phase Chronic Myeloid Leukemia (CML) NCT00114959	ChemGenex Pharmaceuticals	Phase 2